|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/44 | |
| C07D 231/02 | |||
| C07D 401/04 | |||
| C07C 45/65 | |||
| C07C 47/56 |
| (11) | Number of the document | 3454854 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17796828.6 |
| Date of filing the European patent application | 2017-05-11 | |
| (97) | Date of publication of the European application | 2019-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/032104 |
| Date | 2017-05-11 |
| (87) | Number | WO 2017/197083 |
| Date | 2017-11-16 |
| (30) | Number | Date | Country code |
| 201662335583 P | 2016-05-12 | US |
| (72) |
LI, Zhe, US
GUZ, Nathan, US
SHAO, Yiyang, US
COCUZ, Julieana, US
FRIESER, Markus, US
YIANNIKOUROS, George, Petros, US
LIAO, Liang, US
|
| (73) |
Global Blood Therapeutics, Inc.,
181 Oyster Point Blvd., South San Francisco, CA 94080,
US
|
| (54) | PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE |
| PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE |